| Date | Presentation | Download |
|---|---|---|
| November 21 |
Biostock Life Science Summit |
 |
| November 14 |
Presentation of Q3 2024 |
|
| September 16 |
BioStock Life Science - From Seed To Success |
|
| August 15 |
Presentation of half-year results |
|
| June 4 |
H C Andersen Capital Life Science Seminar |
|
| May 30 |
Biostock Global Forum Presentation |
|
| May 16 |
ExpreS2ion Biotechnologies - Presentation of 2024 first quarter results |
|
| April 17 |
ExpreS2ion Biotechnologies presents at Aktiespararna´s Life Science Day |
|
| March 20 |
ExpreS2ion Biotechnologies at the Økonomisk Ugebrev Life Science Investor Forum |
|
| March 5 |
ExpreS2ion Biotech presents at Stora Aktiedagarna Stockholm |
|
| February 8 |
Presentation of fourth quarter and full-year 2023 results, 8 February 2024 |
|
| January 24 |
Presentation at Redeye Thematic Event: Fight Cancer |
|
| Date | Presentation | Download |
|---|---|---|
| December 14 |
Update on EU-Funded Nipah Virus Vaccine Project |
|
| November 23 |
Finwire interview with CEO Bent Frandsen, 23 November 2023 |
|
| November 22 |
Presentation at Økonomisk Ugebrev Life Science Investor Conference |
|
| November 16 |
Presentation of third quarter 2023 results |
|
| August 31 |
H.C. Andersen Capital Life Science Seminar Presentation |
|
| August 17 |
Presentation of second quarter 2023 results |
|
| June 13 |
Presentation at Aktiespararna's Småbolagsdagarna |
|
| May 16 |
Presentation of first quarter 2023 results with H.C. Andersen Capital |
|
| April 20 |
Investor Presentation at Økonomisk Ugebrev |
|
| 5/4 |
BioStock | ExpreS2ion Biotechnologies CEO on the rights issue |
|
| April 3 |
BioStock | Investor Pitch |
|
| March 31 |
2023 Rights Issue Webinar hosted by HC Andersen Capital |
|
| March 30 |
Swiss Nordic Bio |
|
| February 15 |
Presentation of fourth quarter and full-year 2022 results with H.C. Andersen Capital |
|
| February 11 |
Biotech Showcase |
|